(Q46663949)

English

Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men. The Skaraborg Hypertension and Diabetes Project

scientific article published on 4 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men. The Skaraborg Hypertension and Diabetes Project (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

author name string

Anita Mehner

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

Ulf Lindblad

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

Lennart Råstam

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

Kristina Bengtsson Boström

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

publication date

4 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

64

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

815-820

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

https://scigraph.springernature.com/pub.10.1007/s00228-008-0482-x

0 references

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1007%2FS00228-008-0482-X

21 January 2018

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1007%2FS00228-008-0482-X

21 January 2018

Risk factor clustering in patients with hypertension and non-insulin-dependent diabetes mellitus. The Skaraborg Hypertension Project.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-008-0482-X

21 January 2018

Effect of age and gender on pharmacokinetics of atorvastatin in humans.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-008-0482-X

21 January 2018

Who is using antihypertensive drugs? A prescription analysis from Finland

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Invest

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of lipid-lowering treatment according to lipid level.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Tromso study 2001.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention of cardiovascular diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical treatment and secondary prevention of coronary heart disease in general practice in Iceland

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and diabetes project

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Female advantage in AMI mortality is reversed in patients with type 2 diabetes in the Skaraborg Project.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex-related differences in response of plasma lipids to simvastatin: the Saitama Postmenopausal Lipid Intervention Study. S-POLIS Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipid-lowering therapy in patients with coronary artery disease: sex or age bias?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of low-density lipoprotein cholestrol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE trial)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihypertensive drug treatment in a Swedish community: Skaraborg Hypertension and Diabetes Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertriglyceridemia as a cardiovascular risk factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statin therapy in the elderly: does it make good clinical and economic sense?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18389228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-008-0482-X

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18389228

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46663949&oldid=2125121448"